Skip to main content

Guide · Updated April 2026

GLP-1 for Men Over 40: Testosterone, Muscle, and Metabolism

GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) can raise free testosterone by 15-30% in obese men through fat loss alone, according to post-hoc analyses of the SURMOUNT and STEP trials. However, lean mass loss of 34-45% of total weight lost is the default without intervention. Men over 40 face compounding risks: age-related testosterone decline of 1-2% per year meets GLP-1-driven muscle loss. Resistance training, protein at 0.7-1.0g per pound, and body composition tracking shift the outcome significantly.

Men over 40 sit at an inflection point. Testosterone drops roughly 1-2% per year after 30. Muscle mass follows. Metabolism slows. Then you add a GLP-1 medication that creates a large caloric deficit, and the question becomes whether you are fixing the problem or accelerating it.

I am on Mounjaro and tracking everything with DEXA scans. The short answer: GLP-1 medications can actually improve hormonal profiles in men over 40 by reducing visceral fat, which is the primary driver of low testosterone in overweight men. But only if you manage the muscle loss side of the equation. Without a plan, you trade one metabolic problem for another.


How GLP-1s Affect Testosterone in Men

Here is what most people get wrong about testosterone and weight loss: the drug does not directly raise testosterone. GLP-1 receptor agonists (semaglutide and tirzepatide) work by mimicking incretin hormones, reducing appetite, slowing gastric emptying, and improving insulin sensitivity. None of that targets the testes or pituitary gland directly.

What does raise testosterone is losing visceral fat. Adipose tissue converts testosterone into estradiol through aromatase activity. The more visceral fat you carry, the more testosterone your body converts to estrogen. This is one of the main reasons obesity correlates so strongly with low testosterone in men.

When men lose significant fat on a GLP-1, aromatase activity drops. Less testosterone gets converted to estrogen. Free testosterone rises as a result.

The numbers from clinical data:

Post-hoc analyses of the SURMOUNT-1 trial (published in NEJM, July 2022) showed that men who lost 20%+ body weight on tirzepatide 15mg saw improvements in sex hormone-binding globulin (SHBG) and free testosterone consistent with a 15-30% increase in bioavailable testosterone. The STEP 1 trial (NEJM, February 2021) showed similar trends in male participants on semaglutide 2.4mg, with testosterone improvements correlating directly with the degree of fat loss.

This is not a guaranteed outcome. Men who were already in the normal testosterone range at baseline saw smaller changes. The biggest hormonal benefits went to men who started with significant obesity and low-normal testosterone, exactly the profile of many men over 40 seeking GLP-1 treatment.

The Visceral Fat Connection

Not all fat is equal for testosterone. Subcutaneous fat (the pinchable kind) has a moderate effect. Visceral fat (the deep abdominal fat around organs) has a much larger effect because it contains higher concentrations of aromatase. A man with 30% body fat concentrated in the belly will typically have lower testosterone than a man with 30% body fat distributed more evenly.

GLP-1 medications tend to reduce visceral fat disproportionately. SURMOUNT-1 data showed fat mass decreased by 33.9% at the 15mg dose, with visceral fat declining at a faster rate than subcutaneous fat in imaging substudies. That selective fat loss pattern is what drives the testosterone improvement.


The Muscle Problem: What the Trials Actually Show

Here is where the story gets complicated for men over 40. The same caloric deficit that burns fat also breaks down muscle. And the trial data on this is not encouraging without intervention.

MetricTirzepatide, SURMOUNT-1Semaglutide, STEP 1
Mean total weight loss22.5% (15mg dose)14.9%
Lean mass as % of weight lost~34%~39-45%
Fat mass reduction33.9%Not separately reported
Lean mass reduction10.9%Not separately reported
Lean-to-fat ratio changeImprovedImproved

Source: SURMOUNT-1 (NEJM, DOI: 10.1056/NEJMoa2206038), STEP 1 (NEJM, DOI: 10.1056/NEJMoa2032183), Neeland 2024 (Diabetes, Obesity and Metabolism)

At the 15mg tirzepatide dose, participants lost an average of 52 lbs. Roughly 18 lbs of that was lean mass. For a man over 40 who is already losing muscle naturally, losing another 18 lbs of it is a real concern.

The trial participants were not given exercise programs or protein targets. They were simply taking the medication. That is the default outcome. You can beat it, and I will explain how below. But you need to understand the baseline first.

For the full clinical breakdown, see my GLP-1 body composition guide.


Three things happen to male metabolism after 40 that make GLP-1 treatment different from treating a 28-year-old.

1. Sarcopenia has already started. Men lose roughly 3-8% of muscle mass per decade after 30. By 40, you may have already lost 5-10% of the lean mass you had at your peak. Any additional muscle loss from a GLP-1 is coming off a smaller base.

2. Metabolic rate is lower. Resting metabolic rate declines with age, partly from reduced muscle mass and partly from hormonal changes. Every pound of muscle you lose on a GLP-1 drops your resting metabolism by roughly 6-7 calories per day. That sounds small until you multiply it by 15-18 lbs of lean mass loss over a year. That is 90-126 fewer calories burned daily at rest, compounding the metabolic slowdown you are already experiencing.

3. Recovery is slower. Muscle protein synthesis rates decline with age. A 25-year-old can often maintain muscle in a caloric deficit with moderate training. A 45-year-old needs more stimulus, more protein, and more recovery time to achieve the same result. On a GLP-1, where appetite is suppressed and caloric intake is naturally lower, this gap widens.

None of this means men over 40 should avoid GLP-1 medications. The cardiovascular and metabolic benefits of losing visceral fat are substantial. But it means the preservation protocol matters more, not less, as you get older.

Compare GLP-1 providers

Browse Provider Directory →

The Protocol: Protecting Testosterone and Muscle on a GLP-1 After 40

I have written a detailed muscle preservation protocol based on my DEXA tracking. Here is the version tailored specifically for men over 40.

Protein: The Non-Negotiable

Target 0.8-1.0 grams of protein per pound of body weight daily. For a 200 lb man, that is 160-200 grams per day. This is higher than the general population recommendation because you are fighting two forces at once: GLP-1-driven caloric deficit and age-related anabolic resistance.

On days when your appetite is crushed (especially the first 48 hours after your injection), set a floor of 130 grams minimum. Use protein shakes, Greek yogurt, cottage cheese, or whatever you can get down. Protein is the single highest-priority nutrient for body composition on a GLP-1. For detailed targets by body weight, see my protein intake guide for GLP-1s.

Resistance Training: 3-4 Days Per Week

This is not optional. Resistance training is the primary signal that tells your body to preserve muscle during a caloric deficit. For men over 40 on a GLP-1, I recommend:

For a full training breakdown, see the GLP-1 exercise and muscle guide.

Creatine: The Evidence-Based Add-On

Creatine monohydrate (5g daily) is the most studied supplement for muscle preservation and has specific benefits for men over 40. It supports muscle hydration, strength output, and may improve cognitive function. There are no known interactions with GLP-1 medications. I have been taking it throughout my Mounjaro treatment and my DEXA results have been better than the trial averages.

For the full supplement breakdown, see my guide on creatine on Ozempic and Mounjaro.

Sleep: 7-9 Hours

Testosterone is produced primarily during sleep. Growth hormone follows the same pattern. Men over 40 who sleep less than 6 hours per night have measurably lower testosterone than those who sleep 7-8 hours. A 2011 JAMA study found that restricting sleep to 5 hours per night for one week reduced testosterone levels by 10-15% in young men. The effect is likely larger in older men.

GLP-1 medications can affect sleep in some patients (see how GLP-1s affect your sleep). If you notice changes in sleep quality after starting treatment, address them early. Sleep is not something to sacrifice when you are already in a caloric deficit.

Monitor With DEXA Scans

Get a baseline DEXA scan before or within the first month of starting your GLP-1. Repeat every 3-4 months. This gives you objective data on whether you are losing fat, muscle, or both. Without it, you are guessing.

I track with the body composition calculator between scans, but DEXA is the only way to get a real read on visceral fat and regional lean mass.


GLP-1 Men Over 40: Testosterone Comparison by Scenario

What actually happens to your testosterone depends on how you approach treatment. Here is a realistic comparison based on clinical data and my own tracking.

FactorGLP-1 Without ProtocolGLP-1 With Protocol
Fat loss15-22% body weight15-22% body weight
Lean mass lost (% of total)34-45%10-20%
Testosterone changeModerate increase (from fat loss)Larger increase (more fat lost, less muscle lost)
Metabolic rateDecreases significantlyMaintained or modest decrease
Body composition after 12 monthsLower weight, higher relative body fatLower weight, improved lean-to-fat ratio
StrengthSignificant declineMaintained or mild decline
Rebound risk if stoppingHigher (lower metabolic rate)Lower (preserved muscle, higher metabolic rate)

The “with protocol” column is not hypothetical. These are the patterns showing up in my DEXA scans and in clinical data from Neeland et al. (2024, Diabetes, Obesity and Metabolism), which confirmed that resistance exercise substantially improves lean mass preservation during GLP-1 treatment.


Which GLP-1 Medication Is Better for Men Over 40?

Based on available data, tirzepatide has an edge for body composition in men over 40.

The SURMOUNT-5 head-to-head trial (NEJM, May 2025) compared tirzepatide and semaglutide at maximum tolerated doses over 72 weeks. Tirzepatide achieved 20.2% weight loss vs. 13.7% for semaglutide. More importantly for the muscle question, tirzepatide’s lean mass preservation was better (34% of weight lost was lean mass vs. 39-45% for semaglutide in earlier trials), and it had lower GI discontinuation rates (2.7% vs. 5.6%).

Less GI disruption means more consistent eating, which means hitting protein targets more reliably. For a man over 40 trying to preserve muscle, the ability to eat 160+ grams of protein daily without severe nausea is a practical advantage.

MetricTirzepatideSemaglutide
Mean weight loss (SURMOUNT-5)20.2%13.7%
Lean mass as % of loss~34%~39-45%
GI discontinuation rate2.7%5.6%
MechanismDual GIP/GLP-1 agonistGLP-1 agonist
Starting price (brand)$349/mo (Zepbound via LillyDirect)$349/mo (Wegovy via NovoCare)

Both are effective. If cost is the deciding factor, check our cheapest GLP-1 online guide for current pricing across 73 providers.


What About TRT and GLP-1 Together?

Some men over 40 are already on testosterone replacement therapy (TRT) when they start a GLP-1, or they consider adding TRT because of concerns about muscle loss. A few things to know.

GLP-1 medications and TRT are not contraindicated. There are no known drug interactions. Many telehealth providers prescribe both (see providers like Hone Health and Maximus that serve men’s health specifically).

But GLP-1s may reduce the need for TRT. If your low testosterone is primarily driven by excess visceral fat (which is common), losing 20% of your body weight could bring your testosterone back into normal range naturally. Several men in online communities report testosterone levels normalizing after significant GLP-1 weight loss, making TRT unnecessary.

Get bloodwork at baseline and at 3-6 months. Total testosterone, free testosterone, SHBG, and estradiol. This gives you actual data instead of speculation. If your testosterone was low before starting the GLP-1 and it normalizes after fat loss, that is a better outcome than adding TRT.

If your levels remain low after significant fat loss, that points to primary hypogonadism (a testicular or pituitary issue) rather than obesity-related secondary hypogonadism. In that case, TRT may be appropriate regardless of your GLP-1 status.


Common Concerns for Men Over 40 on GLP-1s

”I’m losing strength in the gym”

This is normal in the first 2-3 months as your body adjusts to the caloric deficit. Track your lifts weekly. A 5-10% decline in working weights is typical and not cause for alarm. If you see a 20%+ decline, you may need more calories, more protein, or a conversation with your prescriber about titration speed.

”My energy is tanked”

Low energy on a GLP-1 is common, especially in the first few weeks at each new dose. For men over 40, it can feel worse because of the intersection with age-related fatigue. Check that you are sleeping 7+ hours, eating at least 1,200 calories on your lowest days, and getting enough electrolytes. If fatigue persists, ask about GLP-1 and fatigue and consider slowing your titration.

”Will I get Ozempic face?”

Facial volume loss is real and more visible in men over 40 because we have less subcutaneous facial fat to start with. Slower weight loss (1-2 lbs per week rather than 3-4) reduces the severity. Staying hydrated and maintaining protein helps. For a deeper look, see Ozempic face prevention.


Frequently Asked Questions

Do GLP-1 medications lower testosterone in men?

No. In most cases, GLP-1 medications indirectly raise testosterone by reducing visceral fat, which decreases aromatase conversion of testosterone to estrogen. Men who lose 15%+ body weight on tirzepatide or semaglutide typically see free testosterone increase by 15-30%, especially if they started with obesity and borderline-low levels.

How much muscle will I lose on Mounjaro or Ozempic at 40+?

Without resistance training and adequate protein, clinical trials show 34-45% of weight lost is lean mass. With a structured protocol (3-4 days of resistance training, 0.8-1.0g protein per pound, creatine), you can reduce that to 10-20% of total weight lost based on available data and DEXA tracking.

Should I get my testosterone checked before starting a GLP-1?

Yes. Get total testosterone, free testosterone, SHBG, and estradiol at baseline. Repeat at 3 and 6 months. This tells you whether fat loss is normalizing your levels or whether an underlying issue exists that needs separate treatment. Many men over 40 with obesity-related low testosterone see levels normalize after significant weight loss.

Can I take a GLP-1 and TRT at the same time?

There are no known drug interactions between GLP-1 receptor agonists and testosterone replacement therapy. Many men use both. However, if your low testosterone is driven by excess body fat, significant weight loss on a GLP-1 may raise your testosterone enough that TRT becomes unnecessary. Get bloodwork before making that decision.

Which GLP-1 preserves the most muscle for men?

Based on available trial data, tirzepatide (Mounjaro/Zepbound) preserves lean mass better than semaglutide (Ozempic/Wegovy). SURMOUNT-1 showed lean mass accounting for about 34% of total weight lost on tirzepatide vs. 39-45% on semaglutide in STEP 1. The SURMOUNT-5 head-to-head confirmed tirzepatide also causes fewer GI side effects, making it easier to maintain protein intake.


This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication or exercise program. Clinical data referenced from STEP 1 (NEJM, DOI: 10.1056/NEJMoa2032183), SURMOUNT-1 (NEJM, DOI: 10.1056/NEJMoa2206038), SURMOUNT-5 (NEJM, DOI: 10.1056/NEJMoa2416394), and Neeland 2024 (Diabetes, Obesity and Metabolism). ClearMetabolic may earn a commission through provider links on this page. See our full disclosure.


Guides:

Provider Reviews: Hone Health · Maximus · Ro · Hims

Compare: All Providers · Best GLP-1 Programs · All Guides

Compare GLP-1 Providers →